Cargando…
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
CC Chemokine Receptor 2 (CCR2) and its endogenous ligand CCL2 are involved in a number of diseases, including atherosclerosis. Several CCR2 antagonists have been developed as potential therapeutic agents, however their in vivo clinical efficacy was limited. In this report, we aimed to determine whet...
Autores principales: | Bot, Ilze, Ortiz Zacarías, Natalia V., de Witte, Wilhelmus E. A., de Vries, Henk, van Santbrink, Peter J., van der Velden, Daniël, Kröner, Mara J., van der Berg, Dirk-Jan, Stamos, Dean, de Lange, Elizabeth C. M., Kuiper, Johan, IJzerman, Adriaan P., Heitman, Laura H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427923/ https://www.ncbi.nlm.nih.gov/pubmed/28246398 http://dx.doi.org/10.1038/s41598-017-00104-z |
Ejemplares similares
-
Local Mast Cell Activation Promotes Neovascularization
por: Bot, Ilze, et al.
Publicado: (2020) -
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
por: Kritikou, Eva, et al.
Publicado: (2016) -
Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
por: Lagraauw, H. Maxime, et al.
Publicado: (2019) -
Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis
por: Amersfoort, Jacob, et al.
Publicado: (2018) -
Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
por: Frodermann, Vanessa, et al.
Publicado: (2015)